ABSTRACT
This work implies the preparation, structural and fluorescent characterization, and application of the 1,8‐naphthalimide‐based fluorescent probe for H2S detection in human blood serum. The mechanism of fluorescent detection of H2S is based on the reduction of the azide group, as the chemical reactive site, in the fluorescent probe structure, to the amino group. Compound 2 possesses another important structural motif, ethanolamine moiety, which modulates physicochemical properties. The synthetic pathway for the preparation of compound 2 is consisted of two reaction steps, and the target compound was prepared with a yield of 56%. The prepared compound 2 was characterized using 1H and 13C NMR spectroscopy and elemental analysis. During the fluorescence spectra measurements, several influences on fluorescence intensity were investigated, including pH, time dependence, selective response, and influence of H2S concentration. The detection limit was calculated, which was 0.16 μmol L−1. For examination of the application of compound 2 for H2S detection in real samples, compound 2 was successfully applied for H2S detection in human blood serum. The concentration of H2S in the human serum sample was 16.2 μmol L−1.The accuracy of H2S determination in human blood serum samples is confirmed by the standard addition method and UV‐Vis spectrophotometry method using methylene blue.
Keywords: 1,8‐naphthalimide; azide group; fluorescent probe; human blood serum; hydrogen sulfide
The target 1,8‐napthalimide‐based fluorescent probe was prepared and successfully applied for H2S detection in human blood serum whereby the concentration of H2S in human blood serum was found to be 16.2 μmol L−1. The accuracy of the developed method was confirmed by the standard addition method and UV‐Vis spectrophotometry method using methylene blue.

1. Introduction
Identifying and detecting small gaseous molecules as signal transmitters in living systems involved in various physiological and pathological processes is of great importance. These molecules are called gasotransmitters and include nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S) [1]. Hydrogen sulfide is the third gasotransmitter that is endogenously generated by the action of three main enzymes, namely, cystathionine‐β‐synthase (CBS), cystathionine‐γ‐lyase (CSE), and 3‐mercaptopyruvate sulfurtransferase (MST) [2]. In the case of enzyme CBS, H2S is produced from cysteine by β‐elimination reaction and by β‐replacement reaction, which implies condensation of cysteine with homocysteine. Enzyme CBS is localized to human chromosome 21 [3] whereby in patients with Down syndrome, CBS levels were found to be 1.5‐fold greater compared to those in healthy individuals. Due to the overproduction of H2S in patients with Down syndrome, mental disorders can occur [4]. As CBS is the main H2S‐forming enzyme in the central nervous system (CBS), CSE is the main H2S‐forming enzyme in the cardiovascular system [5]. The last mentioned enzyme responsible for H2S formation, MST, is mainly localized to neurons in the brain and retina [6].
Furthermore, H2S is an environmental pollutant, a colorless, flammable, and toxic gas with high toxicity. A concentration of 500 ppm [7] of H2S can cause respiratory disorders because the lethal dose of H2S is 1000 ppmv [8]. Moreover, H2S is involved in immune response, signal transduction, and energy production, whereas endogenous H2S plays a role in various physiological functions, including regulating blood pressure, neurotransmission, anti‐inflammatory effects, vasodilation, antioxidation, and apoptosis [9, 10]. According to the literature, the toxicity of H2S can be related to respiratory complex activities in mitochondria, which result in cellular incapability to metabolize oxygen in an oxidative manner [11, 12]. A recent study explained the relationship between H2S levels, asthma, and chronic obstructive pulmonary disease (COPD) [13].
Although H2S has been known as a toxic compound for a long time, according to recent studies, it exhibits an antiapoptotic effect in cancer cells via various mechanisms. One of the mechanisms of action includes reactive oxygen species (ROS) scavenging due to its reducing property [14]. Additionally, ROS in organisms are formed as by‐products of oxygen metabolism and can cause damage to biologically important molecules, although their higher level is related to oxidative stress development. Oxidative stress is a physiological state caused by an imbalance between ROS production and their elimination from the organism [15]. H2S possesses both direct and indirect antioxidant capacities. The direct antioxidant capacity of H2S is related to its chemical properties, which enable it to neutralize ROS. On the contrary, the indirect antioxidant capacity of H2S is related to its regulation of key antioxidant enzymes, including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx) [16, 17]. The enzymes mentioned above are crucial for maintaining redox homeostasis and play a role in ROS neutralization [18].
Considering all the physiological functions of H2S, its detection has become a theme of great importance. For that purpose, a large number of H2S detection methods, including UV–visible (UV‐Vis) spectrophotometry method using methylene blue, electrochemistry, gas chromatography, high‐performance liquid chromatography (HPLC), inductively coupled plasma atomic emission, UV‐Vis absorption spectrometry, and fluorescence spectroscopy, have been developed [19, 20, 21]. Moreover, in the literature, methods are also described, which imply the combination of fluorescence spectroscopy and HPLC in order to detect H2S [22, 23, 24]. For example, Lee et al. [24] prepared a fluorescent probe for selective H2S detection in serum whereby the product formed after the reaction with H2S was confirmed using HPLC. The listed methods possess certain disadvantages; for example, in the case of UV‐Vis spectrophotometry method using methylene blue, the disadvantage is the low detection sensitivity, which is in the micromolar range. Additionally, this method requires a long incubation period, which is not suitable for continuous measurements of H2S in physiological conditions [25, 26]. Chromatography‐based methods are incapable of real‐time monitoring in biological samples, especially under hypoxic or anoxic conditions [25]. Electrochemical methods must be highlighted from the list due to their characteristics: high sensitivity, high selectivity, easy miniaturization, low cost, low detection limit (in the nanomolar range), and simple operation [9, 27]. These methods also exhibit some disadvantages, including a long equilibration time and the requirement for a high pH.
Fluorescence and colorimetric probes possess numerous advantages, including low cost, visualization opportunity, noninvasive nature, high sensitivity, and biocompatibility with living systems, highlighting their important role in detecting H2S in biological systems [28, 29, 30]. The fluorescent methods have the best performance in real‐time H2S monitoring; therefore, many small‐molecule fluorescent probes have been developed for real‐time detection of H2S in physiological conditions.
The general structure of a potential fluorescent probe consists of three main structural motifs: fluorophore, recognition group or chemical reactive site for the target analyte, and, optionally, a linker. Potential fluorescent probes must possess some characteristics, including chemical stability, photostability, and ease of structural modifications. In the literature, the six most common fluorophores are listed, namely, rhodamine, cyanine, and hemicyanine, boron‐dipyrromethene (BODIPY), aggregation‐induced emission fluorogens, coumarin dyes, and 1,8‐naphthalimides (1,8‐NI) [28, 31]. Moreover, 1,8‐NI are among the most used fluorophores in many fluorescent probes. They are a class of fluorophores widely used in different fields, including analytical chemistry, materials, and biochemistry. They are widely represented as the basic structure of the fluorescent probe because of their characteristics like high photostability, easy preparation and structural modification, high fluorescence quantum yield, and large Stokes shift [32]. The 1,8‐NI poses electron deficiency where the imide part has an electron acceptor role, whereas the naphthalene ring has the role of п‐bridge substituents of a different type [31, 33]. The optical properties can be modulated by introducing different substituents on the naphthalene ring. Introducing electron‐donating groups like amino or hydroxyl groups at position C‐4 results in a highly fluorescent structure due to an intramolecular charge transfer (ICT), whereas electron‐withdrawing groups like nitro or azido decrease the fluorescence efficiency and result in weak fluorescence [34]. Bearing that in mind, the 1,8‐NI scaffold was a starting point in the development process of our target fluorescent probe.
The donor–acceptor interaction in the 1,8‐NI structure between the electron‐acceptor carbonyl group of the imide structure and the electron‐donating substituent at position C‐4 enables the polarization of the 1,8‐NI molecule. This polarization produces fluorescent emissions of shades of blue, yellow‐green, and even orange‐red. Based on these facts, a very important modification of the 1,8‐NI scaffold to increase the fluorescence intensity implies the conversion of the electron acceptor into an electron‐donating group [32]. For that purpose, many recognition groups and chemical reactive sites are developed, and their structure depends on the type of target analyte. According to the literature, for H2S detection, azide to amine approach, nucleophilic addition approach, copper displacement approach, and nitro to amine reduction approach are most commonly used [35]. As one of the selective reactive sites for H2S detection is the azide group, it has been widely represented in the fluorescent probe structure. The azide group can mask the fluorescence in the potential fluorophore due to its electron‐withdrawing properties. In the case of the rhodamine scaffold, reducing azide into amine in the presence of H2S enables the conjugation of the aromatic rings, resulting in a highly fluorescent probe [36]. The most important advantages of azide‐based probes include high selectivity for H2S compared with other biologically important biothiols such as cysteine, homocysteine, and glutathione [37]. Guided by that knowledge, introducing the azide group to position C‐4 of the 1,8‐NI scaffold as a chemically reactive site for target analyte H2S was applied in the synthetic approach of the fluorescent probe targeted in our research.
The fluorescent probes are based on selective molecular interactions, which cause changes in the chemical and optical properties of the probe used to detect the target analyte. Large amounts of molecular interaction–based probes are developed, with different mechanisms of action such as photoinduced electron transfer (PET) [38], ICT [39, 40] and fluorescence resonance energy transfer (FRET) [29]. The literature described the advantages of ICT‐based fluorescent probes, such as the plausibility of ratiometric detection and the ability to eliminate environmental and instrument distractions. In this research, our group's approach implied the usage of a simple ICT‐based fluorescent probe for H2S detection in human blood serum. This type of fluorescent probe development implied the binding of the azide group as the reactive site for H2S detection directly on the 1,8‐NI system without using a linker. A PET‐based fluorescent probe consists of fluorophore, recognition group or chemical reactive site, and short spacer, which connects these structural motifs, whereas a FRET‐based probe consists of two fluorophores, an energy donor and an energy receptor connected with unconjugated chemical bonds [41].
One of the objectives of this research implied the usage of the 1,8‐NI‐based fluorescent probe with improved water solubility (log p = 1.88) [42] in comparison with the fluorescent probe prepared in our previous work [43] (log p = 3.37) [42] to detect H2S in human blood serum (Figure 1). Using this fluorescent probe design is possible to investigate the influence of improved solubility on the detection performance of the prepared probe. Water solubility is a key feature of chemical compounds for its application in biological systems [44]. The fluorophore 1,8‐NI structural motif was selected, whereas the azide group was selected as a chemical reactive site for the target analyte, H2S. The satisfactory results were obtained with a previously published 1,8‐NI fluorescent probe with azide group as reactive site for H2S and p‐toluidine moiety on the imide part of the molecule [43]; our group's approach was the preparation of a structurally modified fluorescent probe. This structural modification implied the introduction of ethanolamine moiety on the imide part of the molecule. Based on the literature review, it was found that Yan et al. [45] and Xu et al. [46] prepared structurally the same compound, 1,8‐NI with ethanolamine moiety on the imide part of the molecule and azide group as chemical reactive site for H2S to apply it in bioimaging. In addition, to the best of our knowledge, this fluorescent probe has not previously been used to detect H2S in human serum. The UV‐Vis spectrophotometry method using methylene blue was applied for H2S determination on the same human serum sample as a reference method to demonstrate the applicability and accuracy of the developed fluorescent method.
FIGURE 1.

The synthetic approach of target fluorescent probe.
2. Experimental
2.1. Materials and Methods
Reagents and solvents for the synthesis of compounds were purchased from commercial sources. Thin‐layer chromatography (TLC, solvents, and proportions are given in the text) was performed on Fluka silica gel (60 F254) plates (0.25 mm), Steinheim, Germany. For all experiments, different solvents were used, namely, dimethylformamide (DMF), ethyl acetate (EtOAc), hexane (Hx), ethanol (EtOH), and acetonitrile (ACN).
Visualization was achieved using UV light at 254 nm. Melting points were determined using Stuart Digital Melting Point Apparatus SMP 20, in open capillaries and are uncorrected. 1H and 13C NMR spectra were recorded at room temperature on Bruker Avance III HD spectrometer at 500 and 125 MHz using DMSO‐d6. Chemical shifts (δ) are given in parts per million (ppm) downfield from tetramethylsilane as an internal standard (s = singlet, d = doublet, t = triplet, and dd = doublet of doublets) (Figures –S7). C, H, and N analyses were performed on a Fisons EA 1110 CHNS elemental analyzer (Fisons Instruments, Milan, Italy) (Table S1). The excitation and emission spectra were recorded by Hitachi F‐4500 fluorescence spectrophotometer (Hitachi, Tokyo, Japan [λex = 430 nm, λem = 520 nm, slit widths: 5 nm/10 nm]), whereas other fluorescence measurements were performed by Avantes Sensline AvaSpec‐ULS‐TEC. Vacutainer tubes containing a clot activator (BD Vacutainer, Becton, Dickinson, and Company, Franklin Lakes, NJ, USA) and centrifuge (Rotina 380, Hettich GmbH & Co. KG, Tuttlingen, Germany) were used in the human serum isolation procedure.
2.2. Synthesis
2.2.1. Preparation of 6‐Azido‐1H,3H‐benzo[de]isochromene‐1,3‐dione (1)
4‐Bromo‐1,8‐naphthalic anhydride (150 mg, 0.54 mmol) was dissolved in dry DMF (2 mL), and the reaction mixture was stirred at room temperature for 10 min. NaN3 (105 mg, 1.62 mmol) was added to the reaction mixture and stirred for 2 h at room temperature. Reaction monitoring was achieved by TLC (EtOAc/Hx, 1:1). After the completion of the reaction, the reaction mixture was poured into ice, and the precipitate was filtered off and then washed with water. Compound 1 (106 mg, 82%) was obtained as a yellow solid. m.p. = 187.5°C–188°C, R f = 0.69 (EtOAc/Hx, 1:1).
1H NMR (500 MHz, DMSO‐d6) δ/ppm: 7.80 (d, 1H, J = 8.0 Hz, H‐3), 7.92 (t, 1H, J = 7.8 Hz, H‐6), 8.52 (dd, 2H, J = 3.3, 8.2 Hz, H‐5, H‐7), 8.57 (d, 1H, J = 7.1 Hz, H‐2).
13C NMR (125 MHz, DMSO‐d6) δ/ppm: 115.244, 116.841, 119.712, 124.117, 128.120, 129.994, 131.274, 133.780, 133.809, 144.644, 160.577, 161.160. Anal. calc. for C12H5N3O3 C, 60.26; H, 2.11; N, 17.57; O, 20.07%; Found: C, 58.90; H, 3.40; N, 16.48; O, 21.22%.
2.2.2. Preparation of 6‐Azido‐2‐(2‐hydroxyethyl)‐1H‐benzo[de]isoquinoline‐1,3(2H)‐dione (2)
Compound 1 (100 mg, 0.41 mmol) was dissolved in EtOH (10 mL) under reflux. After dissolving compound 1, ethanolamine (25 mg, 24.8 μL, 0.41 mmol) was added, and the reaction mixture was refluxed for 6 h. The reaction was monitored by TLC (EtOAc/Hx, 1:1). The reaction mixture was cooled to room temperature, and the crude product precipitated, filtered off from the reaction mixture. Corresponding 1,8‐NI derivative, compound 2 (63.8 mg, 56%), brown solid was obtained. m.p. = 169.1°C–170.1°C, R f = 0.41 (EtOAc/Hx, 1:1).
1H NMR (500 MHz, DMSO) δ/ppm: 3.65 (q, 2H, J = 5.9 Hz, 2‐Et), 4.14 (t, 2H, J = 6.6 Hz, 1‐Et), 4.82 (t, 1H, J = 5.4 Hz, OH), 7.70 (d, 1H, J = 8.0 Hz, H‐3), 7.83 (t, 1H, J = 8.0 Hz, H‐6), 8.37 (d, 1H, J = 8.3 Hz, H‐7), 8.42 (d, 1H, J = 8.0 Hz, H‐5), 8.49 (d, 1H, J = 6.9 Hz, H‐2).
13C NMR (125 MHz, DMSO) δ/ppm: 42.3, 58.28, 116.36, 118.75, 122.72, 123.96, 127.72, 128.70, 131.87, 131.97, 143.17, 163.33, 163.79.
Anal. calc. for C14H10N4O3 C, 59.57; H, 3.57; N, 19.85; O, 17.00%; Found: C, 59.25; H, 4.39; N, 17.39; O, 18.97%.
2.3. General Procedure for Fluorescence Spectra Measurements
Absolute EtOH was used for the preparation of solutions of compound 2 (c = 10 μmol L−1), whereas for the preparation of solutions of Na2S, KH2PO4, K2HPO4, Na2SO4, Na2SO3, KSCN, GSH, and cysteine ultrapure water was used. For the fluorescent characterization of compound 2 and its reduced form, their EtOH stock solution was used; excitation spectra (λem. = 520 nm) and emission spectra (λexc. = 430 nm) are presented in Figure S8. Spectra were recorded with the corresponding spectrophotometer with slit widths of exc. 5 nm/emm. 10 nm. Before the measurement, all samples were incubated at 25°C for 15 min. Ultimately, Na2S was used as a source of H2S. All experiments were carried out three times.
2.4. Application of Compound 2 for Detection of H2S in Human Blood Serum
For the purpose of human serum isolation, venous blood samples were drawn into 6‐mL vacutainer tubes containing a clot activator. After collection, the samples were centrifuged at 3600 RPM for 10 min at 4°C to separate the serum. The resulting serum was then divided into the required number of aliquots, which were transferred to microcentrifuge tubes. These aliquots were carefully stored at −80°C. Serum collection and isolation were conducted at the Department of Physiology and Immunology (Laboratory for Molecular and Clinical Immunology), Faculty of Medicine, Osijek, Croatia.
To detect H2S in human serum using a fluorescent probe, ACN (1 mL) was added to the collected aliquot (500 μL) to precipitate the protein in serum [47]. After the precipitation of proteins, a clear supernatant was diluted to 5 mL using distilled water. A clear supernatant (250 μL), PBS buffer (250 μL, pH = 7.4), Na2S (250 μL, 5, 10, 15, and 20 μmol L−1), and a solution of compound 2 (250 μL, 10 μmol L−1) were added to four Eppendorf tubes. For recording the 0 point (blank), a clear supernatant (250 μL), PBS buffer (250 μL, pH = 7.4), ZnCl2 (250 μL, 100 μmol L−1), and a solution of compound 2 (250 μL, 10 μmol L−1) were added to an Eppendorf tube. For recording the X point, instead of ZnCl2, distilled water (250 μL) was added to the Eppendorf tube.
All six Eppendorf tubes were incubated for 30 min at 37°C. Ultimately, before measurement, absolute EtOH (1 mL) was added to all six Eppendorf tubes.
2.5. Application of UV‐Vis Spectrophotometry Method Using Methylene Blue for H2S Detection in Human Blood Serum
Into the aliquot of human blood serum (500 μL) ACN (1 mL) was added. After the precipitation of proteins, a clear supernatant was diluted to 5 mL using distilled water. Into an Eppendorf tube, diluted supernatant (250 μL), trichloroacetic acid (300 μL, 10%), zinc acetate (150 μL, 1%), N,N‐dimethyl‐p‐phenylenediamine sulfate in 7.2 mol L−1 HCl (100 μL, 20 μmol L−1), and FeCl3 in 1.2 mol L−1 HCl (133 μL, 30 μmol L−1) were added. The absorbance of the resulting solution was measured 15 min later. All samples were spiked with the same concentrations as in the fluorescent method, although the concentration of H2S was calculated from a calibration curve.
3. Results and Discussion
3.1. Chemistry
This work implied the development and synthesis of the 1,8‐NI derivative, fluorescent probe, compound 2. The synthesis of compound 2 was carried out according to Zhang et al. [48]. The literature‐described procedure implied two reaction steps, whereby, in the case of this work, the first reaction step was modified. This modification included the addition of 3 equiv. of NaN3 and the addition of NaN3 to the solution of 4‐bromo‐1,8‐naphthalic anhydride without previous dissolving in water. The synthetic route carried out for the preparation of the target compound 2 is described in Scheme 1. As a starting compound, the commercially available 4‐bromo‐1,8‐naphthalic anhydride was used. The first reaction step implied nucleophilic aromatic substitution on the starting compound with the aim of introducing the azide group as a chemically reactive site for H2S in the 1,8‐NI structure, whereby compound 1 was synthesized with a satisfactory yield of 82%. The second reaction step included the binding of the ethanolamine moiety on the N‐position of the 1,8‐NI structure, which resulted in the formation of the target compound 2, with a yield of 56%. The synthesized compounds 1 and 2 were characterized by 1H and 13C NMR spectroscopy and elemental analysis (Figures –S7 and Table S1).
SCHEME 1.

Synthetic route for the preparation of compound 2 and NMR numbering scheme.
3.2. Investigation of Effect of pH and Time Dependence of Compound 2
For the purpose of investigating the detection performance of compound 2, the influence of pH change on fluorescence intensity was studied (Figure 2 and Table S2). An experiment was carried out in PBS buffer in the pH range 2–12, with a large number of measurements in the range of 5.8–8, slightly above and below the biologically relevant pH range, as the pH of human serum is 7.35–7.45 [49]. Compound 2, without the addition of H2S, was not sensitive to the biologically relevant pH range over 2–12. After the addition of H2S, an enhanced fluorescence peak at 520 nm appeared in the range of 6.8–7.6, whereas the maximum peak of fluorescence intensity appeared at a pH of 7.4. Considering the literature value of the pH of human serum, it can be concluded that compound 2 has great potential to be used for H2S detection in the pH conditions of human serum (Figure 2).
FIGURE 2.

Fluorescence intensities of compound 2 (10 μmol L−1) at 520 nm with and without addition of H2S at pH range of 2–12.
Solution of compound 2 (10 μmol L−1) was treated with three different concentrations of H2S (5, 10, and 20 μmol L−1) during 1 h, 0–60 min after H2S addition with the aim of investigating the fluorescent response of compound 2 to H2S. Spectra were recorded every 2 min (Figures 3, 4, 5) at three biologically relevant pH values (7–7.4) for all three concentrations of H2S, considering that the percentage composition of sulfide in plasma is sensitive to the pH [50]. During the period of 1 h in the case of all three chosen concentrations of H2S at selected pH values, an increase in fluorescence intensity was observed.
FIGURE 3.

Fluorescence intensity of compound 2 (10 μmol L−1) after treatment with H2S (5 μmol L−1). Fluorescence intensity was recorded at 520 nm. Time points represent 0–60 min; after H2S addition, spectra were recorded every 2 min. Experiment was conducted at (a) pH = 7.0, (b) pH = 7.2, and (c) pH = 7.4.
FIGURE 4.

Fluorescence intensity of compound 2 (10 μmol L−1) after treatment with H2S (10 μmol L−1). Fluorescence intensity was recorded at 520 nm. Time points represent 0–60 min; after H2S addition, spectra were recorded every 2 min. Experiment was conducted at (a) pH = 7.0, (b) pH = 7.2, and (c) pH = 7.4.
FIGURE 5.

Fluorescence intensity of compound 2 (10 μmol L−1) after treatment with H2S (20 μmol L−1). Fluorescence intensity was recorded at 520 nm. Time points represent 0–60 min; after H2S addition, spectra were recorded every 2 min. Experiment was conducted at (a) pH = 7.0, (b) pH = 7.2, and (c) pH = 7.4.
Fluorescence intensities of compound 2 (10 μmol L−1) at 520 nm after treatment with three different concentrations of Na2S (5, 10, and 20 μmol L−1) at three pH values (7–7.4) in the reaction period of 1 h are investigated. In the case of all three pH values (a–c), the same trend is observed. The fluorescence intensity of probe 2 after treatment with all three selected concentrations of Na2S increased during the time and became constant after approximately 30–40 min (Figure 6). From Figure 6, it is evident that in the case of 20 μmol L−1, Na2S fluorescence intensity was higher and increased during the period of approximately 50 min for all three pH values. This trend can be explained by mechanistic insight for reducing aryl azides with H2S. Henthorn and Pluth [51] explained that HS− is the reactive species required for the aryl azide reduction whereby two HS equivalents are required for complete reduction of the azide group.
FIGURE 6.

Fluorescence intensity of compound 2 (10 μmol L−1) after treatment with H2S (10 and 20 μmol L−1). Fluorescence intensity was recorded at 520 nm. Time points represents 0–60 min; after H2S addition, spectra were recorded every 2 min. Experiment was conducted at (a) pH = 7.0, (b) pH = 7.2, and (c) pH = 7.4.
3.3. Investigation of Selective Response of Compound 2 to H2S
To confirm the ability of probe 2 to detect H2S and to investigate the possibility of its application in biological systems, more precisely human blood serum, the selectivity of compound 2 for H2S detection was examined. For that purpose, as analytes (50 equiv.), except Na2S, KSCN, Na2SO3, and Na2SO4, biologically important thiols cysteine (Cys) and glutathione (GSH) were chosen (Figures 7 and 8 and Table S3). Moreover, with the aim of additionally confirming the ability of probe 2 to selectively detect H2S in human serum, experiments were also carried out in the presence of 500 equiv. Cys and GSH. From Figures 7 and 8, it is evident that the change in fluorescence intensity after treatment with other analytes was insignificant in comparison with Na2S. These results indicate the possibility of the application of probe 2 for selective H2S detection in human blood serum.
FIGURE 7.

Fluorescence intensity response of compound 2 to selected analytes at three biological relevant pH values of (a) pH = 7.0, (b) pH = 7.2, and (c) pH = 7.4.
FIGURE 8.

Fluorescent emission spectra of compound 2 after treatment with selected analytes at three biological relevant pH values of (a) pH = 7.0, (b) pH = 7.2, and (c) pH = 7.4.
3.4. Investigation of Influence of Concentration of Na2S on Fluorescence Intensity
The reduction of compound 2 (10 μmol L−1) was carried out with different concentrations of H2S in the range of 0–300 μmol L−1 for the purpose of examining the detection performance of the fluorescent probe, mainly, detection limit calculation. The mentioned range is selected according to the literature‐described concentration range of H2S in blood or plasma 10–300 μmol L−1 [52]. Fluorescent emission spectra of compound 2 after treatment with the mentioned concentration of Na2S are recorded and presented in Figure 9.
FIGURE 9.

Fluorescent emission spectra of compound 2 after treatment with Na2S in the concentration range of 0–300 μmol L−1.
The dependence of fluorescence intensity on mentioned concentrations was examined, and the corresponding graph was plotted (Figure S9). From the plotted graph, it was observed that in the concentration range of 0–20 μmol L−1, an excellent linearity relationship was obtained although increasing the concentration caused a significant lack of linearity. One of the possible explanations for that trend can also imply the mechanistic insight [51] according to which for complete reduction of compound 2 with H2S, 2 equiv. of H2S are required.
For the prepared probe, compound 2, the detection limit (3σ/k) was calculated after 30 min incubation with H2S in PBS buffer at pH = 7.4. The value of the detection limit was found to be 0.16 μmol L−1 (Figure S9). According to the literature evidence for this fluorescent probe, prepared by Yan et al., a minimum concentration was calculated to be 1 × 10−7 mol·L−1, whereas in the case of research by Xu et al. [46], the detection limit was calculated to be 1.09 μmol L−1. These results can be compared to our obtained value of the detection limit. Furthermore, for the structurally similar compounds, the detection limit was found to be in the range of 0.02–0.7 μmol L−1 [48, 53, 54]. More precisely, in the case of the 1,8‐NI‐based probe with metoxyaniline moiety on the imide part of the molecule, the detection limit was calculated to be 0.017 μmol L−1 [53]. In addition, in the instance of the hydroxyaniline‐functionalized probe, the detection limit was calculated to be 0.051 μmol L−1 [48]. In both cases, the values of the detection limit are lower in comparison with compound 2 from this research. But, in the case of the propyl group functionalized 1,8‐NI probe [54], the calculated value of the detection limit was found to be 0.74 μmol L−1, which is higher in comparison with compound 2 from this research. On the basis of this comparison, and considering the research from Yan et al. [45] and Xu et al. [46] for the structurally the same probe, it can be concluded that the results from our research are comparable with those obtained in the literature‐described research.
The detection limit of the previously prepared probe by our group was found to be 0.085 μmol L−1. Because in the case of this probe development we were guided by the idea of the decreasing log P, in order to increase solubility and ultimately to decrease the detection limit, we compared the obtained results with those from previous work [43]. On the basis of the obtained results, it can be concluded that the increase in water solubility does not have a significant influence on the detection performance of the probe for the purpose of H2S detection in human blood serum.
3.5. Application of Compound 2 in Quantitative Detection of H2S in Human Serum and Comparison With UV‐Vis Spectrophotometry Method Using Methylene Blue
The prepared fluorescent probe 2 was successfully applied in H2S detection in human blood serum. The standard addition method was used for confirmation of the accuracy of the H2S determination, whereby Na2S was spiked as an internal standard. The selected concentrations of Na2S used for spiking human blood serum samples were chosen to be 5, 10, 15, and 20 μmol L−1 due to the linear relationship between fluorescence intensity and concentration in the concentration range of 5–20 μmol L−1. For the 0 point (blank), ZnCl2 was added to a human serum sample in order to remove H2S from the sample [55]. All samples were incubated at 37°C after which fluorescence spectra were measured. The concentration of H2S in the human serum sample was found to be 16.2 μmol L−1, whereby the concentration was calculated as the ratio of intercept and slope (Figure S10). In Table 1, the spiked level of Na2S in the human serum sample and the recovery values are presented. Considering the literature value of physiological serum concentration of H2S, which is in the range of 10–300 μmol L−1 [52], it can be observed that there is accordance of our obtained results with those described in the literature. In comparison with the literature‐described results, the obtained concentration of H2S in the human serum sample in this research is lower. This fact can be explained by the transient nature of H2S and its low concentration in different tissues [52, 55].
TABLE 1.
Determination of H2S in human serum sample using standard addition method in fluorescent probe detection and UV‐Vis spectrophotometry method using methylene blue.
| Found (μmol L −1 ) | Recovery (%) | RSD (%) | |||||
|---|---|---|---|---|---|---|---|
| Added (μmol L−1) | Fluorescence | Methylene blue | Fluorescence | Methylene blue | Fluorescence | Methylene blue | |
| Human serum | 5 | 4.4 | 5.2 | 88 | 104 | 9 | 3 |
| 10 | 9.8 | 10.1 | 98 | 101 | 1 | 1 | |
| 15 | 15 | 14.5 | 100 | 97 | 0 | 2 | |
| 20 | 20.2 | 20.3 | 101 | 102 | 1 | 1 | |
Abbreviation: RSD, relative standard deviation.
In order to investigate the applicability and the accuracy of the developed method, UV‐Vis spectrophotometry method using methylene blue, as the most commonly used method for sulfide measurement in biological samples, was applied. This method implies the reaction of N,N‐dimethyl‐p‐phenylenediamine, sulfide, and FeCl3 in order to produce methylene blue dye, which can be detected spectrophotometrically [56, 57]. The described method was applied to the same human serum sample as in the case of the application of fluorescent probe 2. The concentration of H2S was found to be 17.1 μmol L−1, whereby concentration was calculated as the ratio of intercept and slope (Figure S10).
4. Conclusion
A novel fluorescent probe for the purpose of H2S detection in human blood serum was prepared. The prepared fluorescent probe, compound 2, in its structure possesses 1,8‐NI scaffold as fluorophore, azide group as chemical reactive site for H2S, and ethanolamine moiety for modulation of physicochemical properties, more precisely, increase of water solubility. The azide group is directly bound to a fluorophore, without the usage of a linker, based on which it can be concluded that the prepared fluorescent probe is an ICT‐based probe. Several effects on fluorescence intensity were investigated, including the effect of pH and the time dependence of compound 2, the selective response of probe 2 to H2S, and the influence of the concentration of Na2S as a source of H2S. The calculated detection limit for the fluorescent probe, compound 2, was 0.16 μmol L−1 for the linear range of 0–20 μmol L−1.
To investigate the potential application of probe 2 in biological systems, compound 2 was applied for H2S detection in human blood serum whereby the concentration of H2S was found to be 16.2 μmol L−1. Furthermore, in order to investigate and confirm the utilization of fluorescent probe 2 for H2S determination in biological samples, a commonly used method for H2S determination was applied on the same human serum sample. Applying the UV‐Vis spectrophotometry method using methylene blue, H2S concentration was found to be 17.1 μmol L−1. The obtained results with the novel fluorescent probe 2 are in accordance with those obtained applying the UV‐Vis spectrophotometry method using methylene blue, indicating that the developed method could be used for selective and accurate H2S detection in biological samples, primarily in human blood serum.
Author Contributions
Aleksandar Széchenyi: writing – review and editing, funding acquisition, methodology, conceptualization, investigation. Mirela Samardžić: validation, supervision. Mateja Budetić: validation, methodology. Ines Drenjančević: formal analysis, supervision. Nikolina Kolobarić: formal analysis, investigation. Gábor Mikle: formal analysis. Barna Kovács: methodology, data curation. Andrea Dandić: writing – original draft, investigation, methodology, conceptualization, visualization, formal analysis, data curation. All authors have critically revised the first version and have approved the final version of the manuscript.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Figure S1: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 1.
Figure S2: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 1.
Figure S3: bio70295‐sup‐0001‐Supplementary_Material.docx. 13C NMR of compound 1.
Figure S4: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 2.
Figure S5: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 2.
Figure S6: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 2.
Figure S7: bio70295‐sup‐0001‐Supplementary_Material.docx. 13C NMR of compound 2.
Table S1:. Elemental analysis of prepared compounds.
Table S2: Fluorescence intensities of compound 2 (10 μmol L−1) at 520 nm with and without addition of H2S at pH values in the range of 2–12.
Table S3: Fluorescence intensity response of compound 2 to selected analytes at three biological relevant pH values pH = 7.0, pH = 7.2 and pH = 7.4.
Figure S8: (a) Emission spectra of compound 2 excitation at 430 nm, (b) excitation spectra of compound 2 emission at 520 nm, (c) emission spectra of reduced form of compound 2 excitation at 430 nm, and (d) excitation spectra of reduced form of compound 2 emission at 520 nm.
Figure S9: Plot of the fluorescence intensity of compound 2 (10 μmol L−1) in the (a) concentration range of 0–20 μmol L−1 of H2S at 520 nm and (b) concentration range of 0–300 μmol L−1 of H2S at 520 nm.
Figure S10: Determination of H2S concentration in spiked human serum sample using Na2S as internal standard (5–20 μmol L−1) by (a) fluorescent probe detection at 520 nm and (b) UV‐Vis spectrophotometry method using methylene blue in spiked human plasma sample using Na2S as internal standard (5–20 μmol L−1) at 570 nm.
Acknowledgments
The authors wish to thank kindly Dr. Cecìlia Pàpaynè Sàr, University of Pècs and Jànos Szentàgothai Science Center, Hungary, for performing elemental analysis of the prepared compounds. Open access publishing facilitated by Sveuciliste Josipa Jurja Strossmayera u Osijeku, as part of the Wiley – National and University Library in Zagreb Consortium Croatian Academic and Research Libraries Consortium agreement.
Széchenyi A., Samardžić M., Budetić M., et al., “Development and Application of a 1,8‐Naphthalimide‐Based Fluorescent Probe for Sensitive Detection of Hydrogen Sulfide in Human Blood Serum,” Luminescence 40, no. 8 (2025): e70295, 10.1002/bio.70295.
Funding: The authors received no specific funding for this work.
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
References
- 1. Wang R., “Gasotransmitters: Growing Pains and Joys,” Trends in Biochemical Sciences 39 (2014): 227–232. [DOI] [PubMed] [Google Scholar]
- 2. Szabo C., “Gasotransmitters in Cancer: From Pathophysiology to Experimental Therapy,” Nature Reviews Drug Discovery 15 (2016): 185–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Wisniewski K. E., Wisniewski H. M., and Wen G. Y., “Occurrence of Neuropathological Changes and Dementia of Alzheimer's Disease in Down's Syndrome,” Annals of Neurology 17 (1985): 278–282. [DOI] [PubMed] [Google Scholar]
- 4. Kimura H., Shibuya N., and Kimura Y., “Hydrogen Sulfide Is a Signaling Molecule and a Cytoprotectant,” Antioxidants and Redox Signaling 17 (2012): 45–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Moore P. K., Bhatia M., and Moochhala S., “Hydrogen Sulfide: From the Smell of the Past to the Mediator of the Future?,” Trends in Pharmacological Sciences 24 (2003): 609–611. [DOI] [PubMed] [Google Scholar]
- 6. Mikami Y., Shibuya N., Kimura Y., Nagahara N., Yamada M., and Kimura H., “Hydrogen Sulfide Protects the Retina From Light‐Induced Degeneration by the Modulation of Ca2+ Influx,” Journal of Biological Chemistry 286 (2011): 39379–39386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Zhang H., Xia X., Zhao H., et al., “A Near‐Infrared Fluorescent Probe Based on SNAr Reaction for H2S/GSH Detection in Living Cells and Zebrafish,” Dyes and Pigments 163 (2019): 183–189. [Google Scholar]
- 8. Urriza‐Arsuaga I., Bedoya M., and Orellana G., “Unprecedented Reversible Real‐Time Luminescent Sensing of H2S in the Gas Phase,” Analytical Chemistry 91 (2019): 2231–2238. [DOI] [PubMed] [Google Scholar]
- 9. Yang M., Zhou Y., Wang K., et al., “Review of Chemical Sensors for Hydrogen Sulfide Detection in Organisms and Living Cells,” Sensors (Basel) 23 (2023): 3316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Oguz A., Oguz M., Kursunlu A. N., and Yilmaz M., “A Fully Water‐Soluble Calix[4]arene Probe for Fluorometric and Colorimetric Detection of Toxic Hydrosulfide and Cyanide Ions: Practicability in Living Cells and Food Samples,” Food Chemistry 401 (2023): 134132. [DOI] [PubMed] [Google Scholar]
- 11. Abou‐Hamdan A., Guedouari‐Bounihi H., Lenoir V., Andriamihaja M., Blachier F., and Bouillaud F., “Oxidation of H2S in Mammalian Cells and Mitochondria,” Methods in Enzymology 554 (2015): 201–228. [DOI] [PubMed] [Google Scholar]
- 12. Reiffenstein R. J., Hulbert W. C., and Roth S. H., “Toxicology of Hydrogen Sulfide,” Annual Review of Pharmacology and Toxicology 32 (1992): 109–134. [DOI] [PubMed] [Google Scholar]
- 13. Khattak S., Zhang Q. Q., Sarfraz M., et al., “The Role of Hydrogen Sulfide in Respiratory Diseases,” Biomolecules 11 (2021): 1–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Gao W., Liu Y. F., Zhang Y. X., et al., “The Potential Role of Hydrogen Sulfide in Cancer Cell Apoptosis,” Cell Death Discovery 10 (2024): 1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Pizzino G., Irrera N., Cucinotta M., et al., “Oxidative Stress: Harms and Benefits for Human Health,” Oxidative Medicine and Cellular Longevity 2017 (2017): 8416763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Putman A. K., Contreras G. A., and Mottillo E. P., “Thermogenic Adipose Redox Mechanisms: Potential Targets for Metabolic Disease Therapies,” Antioxidants (Basel, Switzerland) 12 (2023): 196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Benchoam D., Semelak J. A., Cuevasanta E., et al., “Acidity and Nucleophilic Reactivity of Glutathione Persulfide,” Journal of Biological Chemistry 295 (2020): 15466–15481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Li Y., Zhang X., Wang Z., Li B., and Zhu H., “Modulation of Redox Homeostasis: A Strategy to Overcome Cancer Drug Resistance,” Frontiers in Pharmacology 14 (2023): 1156538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Yuan Z., Lu F., Peng M., et al., “Selective Colorimetric Detection of Hydrogen Sulfide Based on Primary Amine‐Active Ester Cross‐Linking of Gold Nanoparticles,” Analytical Chemistry 87 (2015): 7267–7273. [DOI] [PubMed] [Google Scholar]
- 20. Li L., Rose P., and Moore P. K., “Hydrogen Sulfide and Cell Signaling,” Annual Review of Pharmacology and Toxicology 51 (2011): 169–187. [DOI] [PubMed] [Google Scholar]
- 21. Smith H. M. and Pluth M. D., “Advances and Opportunities in H2S Measurement in Chemical Biology,” JACS Au 3 (2023): 2677–2691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Shen X., Kolluru G. K., Yuan S., and Kevil C. G., “Measurement of H2S In Vivo and In Vitro by the Monobromobimane Method,” Methods in Enzimology 554 (2015): 31–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Pose M., Dillon K. M., Denicola A., et al., “Fluorescent Detection of Hydrogen Sulfide (H2S) Through the Formation of Pyrene Excimers Enhances H2S Quantification in Biochemical Systems,” Journal of Biological Chemistry 298 (2022): 102402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Lee S., Sung D. B., Lee J. S., and Han M. S., “A Fluorescent Probe for Selective Facile Detection of H2S in Serum Based on an Albumin‐Binding Fluorophore and Effective Masking Reagent,” ACS Omega 5 (2020): 32507–32514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Xu T., Scafa N., Xu L. P., et al., “Electrochemical Hydrogen Sulfide Biosensors,” Analyst 141 (2016): 1185–1195. [DOI] [PubMed] [Google Scholar]
- 26. Olson K. R., “A Practical Look at the Chemistry and Biology of Hydrogen Sulfide,” Antioxidants & Redox Signaling 17 (2012): 32–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Zhao Y., Yang Y., Cui L., Zheng F., and Song Q., “Electroactive Au@Ag Nanoparticles Driven Electrochemical Sensor for Endogenous H2S Detection,” Biosensors and Bioelectronics 117 (2018): 53–59. [DOI] [PubMed] [Google Scholar]
- 28. Li H., Fang Y., Yan J., et al., “Small‐Molecule Fluorescent Probes for H2S Detection: Advances and Perspectives,” TrAC Trends in Analytical Chemistry 134 (2021): 6195. [Google Scholar]
- 29. Wei B. Y., Yan X. M., Yuan Y. C., Miao J. Y., Zhao B. X., and Lin Z. M., “A Rhodol‐Based Fluorescent Probe for Ratiometric Sensing of Hydrogen Sulfide in Living Cells,” Journal of Photochemistry and Photobiology. A, Chemistry 450 (2024): 115450. [Google Scholar]
- 30. Muthusamy S., Rajalakshmi K., Zhu D., Zhao L., Wang S., and Zhu W., “A Novel Lysosome Targeted Fluorophore for H2S Sensing: Enhancing the Quantitative Detection With Successive Reaction Sites,” Sensors and Actuators, B: Chemical 320 (2020): 128433. [Google Scholar]
- 31. Geng Y., Wang Z., Zhou J., Zhu M., Liu J., and James T. D., “Recent Progress in the Development of Fluorescent Probes for Imaging Pathological Oxidative Stress,” Chemical Society Reviews 52 (2023): 3873–3926. [DOI] [PubMed] [Google Scholar]
- 32. Dong H. Q., Wei T. B., Ma X. Q., et al., “1,8‐Naphthalimide‐Based Fluorescent Chemosensors: Recent Advances and Perspectives,” Journal of Materials Chemistry C 8 (2020): 13501–13529. [Google Scholar]
- 33. Szakács Z., Rousseva S., Bojtár M., et al., “Experimental Evidence of TICT State in 4‐Piperidinyl‐1,8‐naphthalimide‐A Kinetic and Mechanistic Study,” Physical Chemistry Chemical Physics 20 (2018): 10155–10164. [DOI] [PubMed] [Google Scholar]
- 34. Meka R. K. and Heagy M. D., “Selective Modulation of Internal Charge Transfer and Photoinduced Electron Transfer Processes in N‐Aryl‐1,8‐naphthalimide Derivatives: Applications in Reaction‐Based Fluorogenic Sensing of Sulfide,” Journal of Organic Chemistry 82 (2017): 12153–12161. [DOI] [PubMed] [Google Scholar]
- 35. Kumar N., Bhalla V., and Kumar M., “Recent Developments of Fluorescent Probes for the Detection of Gasotransmitters (NO, CO and H2S),” Coordination Chemistry Reviews 257 (2013): 2335–2347. [Google Scholar]
- 36. Lin V. S., Lippert A. R., and Chang C. J., “Azide‐Based Fluorescent Probes: Imaging Hydrogen Sulfide in Living Systems,” Methods in Enzymology 554 (2015): 63–80. [DOI] [PubMed] [Google Scholar]
- 37. Lippert A. R., New E. J., and Chang C. J., “Reaction‐Based Fluorescent Probes for Selective Imaging of Hydrogen Sulfide in Living Cells,” Journal of the American Chemical Society 133 (2011): 10078–10080. [DOI] [PubMed] [Google Scholar]
- 38. Niu H., Liu J., O'Connor H. M., Gunnlaugsson T., James T. D., and Zhang H., “Photoinduced Electron Transfer (PeT) Based Fluorescent Probes for Cellular Imaging and Disease Therapy,” Chemical Society Reviews 52 (2023): 2322–2357. [DOI] [PubMed] [Google Scholar]
- 39. Rajalakshmi K., Muthusamy S., Lee H. J., et al., “Dual‐Channel Fluorescent Probe for Discriminative Detection of H2S and N2H4: Exploring Sensing Mechanism and Real‐Time Applications,” Journal of Hazardous Materials 465 (2024): 133036. [DOI] [PubMed] [Google Scholar]
- 40. Xun Y., Nan G., Ahn D. H., et al., “A Coumarin‐Based Fluorescent Probe for Imaging H2S and Distinguishing Breast Cancer Cells From Normal Ones,” Journal of Molecular Liquids 414 (2024): 126158. [Google Scholar]
- 41. Yang C., “Molecular Interaction‐Based Fluorescence Sensing Technologies and Their Application,” Highlights in Science, Engineering and Technology 14 (2022): 34–43. [Google Scholar]
- 42.“On‐Line Lipophilicity/Aqueous Solubility Calculation Software,” (n.d.), accessed December 15, 2024.
- 43. Dandić A., Samardžić M., Budetić M., et al., “Design and Characterization of Novel Naphthalimide Fluorescent Probe for H2S Detection in Human Serum,” Journal of Fluorescence (2024), 10.1007/s10895-024-04071-3. [DOI] [PubMed] [Google Scholar]
- 44. Wang X. B., Li H. J., Liu C., Lu W. Y., Lu X., and Wu Y. C., “A Water‐Soluble Turn‐On Fluorescent Probe for Rapid Discrimination and Imaging of Cys/Hcy and GSH in Cells and Zebrafish Through Different Fluorescent Channels,” Dyes and Pigments 199 (2022): 110058. [Google Scholar]
- 45. Yan Y., Zhu S., Chen Z., and Ji Y., “A Novel Turn‐On the Fluorescence Sensor for H2S and Its Applications in Bioimaging,” Journal of Applied Spectroscopy 89 (2022): 191–200. [Google Scholar]
- 46. Xu Q., He L., Wei H., and Lin W., “An ICT‐Based Hydrogen Sulfide Sensor With Good Water Solubility for Fluorescence Imaging in Living Cells,” Journal of Fluorescence 28 (2018): 5–11. [DOI] [PubMed] [Google Scholar]
- 47. Sreejith S., Divya K. P., and Ajayaghosh A., “A Near‐Infrared Squaraine Dye as a Latent Ratiometric Fluorophore for the Detection of Aminothiol Content in Blood Plasma,” Angewandte Chemie International Edition 47 (2008): 7883–7887. [DOI] [PubMed] [Google Scholar]
- 48. Zhang Y. and Zhang L., “A Novel “Turn‐On” Fluorescent Probe Based on Hydroxy Functionalized Naphthalimide as a Logic Platform for Visual Recognition of H2S in Environment and Living Cells,” Spectrochimica Acta ‐ Part A: Molecular and Biomolecular Spectroscopy 235 (2020): 118331. [DOI] [PubMed] [Google Scholar]
- 49. Hopkins E., Sanvictores T., and Sharma S., Physiology, Acid Base Balance (StatPearls Publishing LLC, 2022): 19–22. [PubMed] [Google Scholar]
- 50. Karunya R., Jayaprakash K. S., Gaikwad R., et al., “Rapid Measurement of Hydrogen Sulphide in Human Blood Plasma Using a Microfluidic Method,” Scientific Reports 9 (2019): 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Henthorn H. A. and Pluth M. D., “Mechanistic Insights Into the H2S‐Mediated Reduction of Aryl Azides Commonly Used in H2S Detection,” Journal of the American Chemical Society 137 (2015): 15330–15336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Whitfield N. L., Kreimier E. L., Verdial F. C., Skovgaard N., and Olson K. R., “Reappraisal of H2S/Sulfide Concentration in Vertebrate Blood and Its Potential Significance in Ischemic Preconditioning and Vascular Signaling,” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 294 (2008): 1930–1937. [DOI] [PubMed] [Google Scholar]
- 53. Zhang Y. and Zhang L., “A Novel “Turn‐On” Fluorescent Probe Based on Naphthalimide for Monitoring H2S Levels in Living Cells and Red Wine,” Microchemical Journal 159 (2020): 105394. [Google Scholar]
- 54. Ding D., Li J., Xu L., Wang J., Tan D., and Lin W., “Development of an Activatable Hydrogen Sulfide‐Specific Two‐Photon Fluorescent Probe for Bioimaging in an Air Pouch Inflammation Model,” Journal of Materials Chemistry B 10 (2022): 4568–4574. [DOI] [PubMed] [Google Scholar]
- 55. Qian Y., Zhang L., Ding S., et al., “A Fluorescent Probe for Rapid Detection of Hydrogen Sulfide in Blood Plasma and Brain Tissues in Mice,” Chemical Science 3 (2012): 2920–2923. [Google Scholar]
- 56. Nagy P., Pálinkás Z., Nagy A., Budai B., Tóth I., and Vasas A., “Chemical Aspects of Hydrogen Sulfide Measurements in Physiological Samples,” Biochimica et Biophysica Acta 1840 (2014): 876–891. [DOI] [PubMed] [Google Scholar]
- 57. Mok Y. Y. P., Mohammed Atan M. S. B., Ping C. Y., et al., “Role of Hydrogen Sulphide in Haemorrhagic Shock in the Rat: Protective Effect of Inhibitors of Hydrogen Sulphide Biosynthesis,” British Journal of Pharmacology 143 (2004): 881–889. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Figure S1: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 1.
Figure S2: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 1.
Figure S3: bio70295‐sup‐0001‐Supplementary_Material.docx. 13C NMR of compound 1.
Figure S4: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 2.
Figure S5: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 2.
Figure S6: bio70295‐sup‐0001‐Supplementary_Material.docx. 1H NMR of compound 2.
Figure S7: bio70295‐sup‐0001‐Supplementary_Material.docx. 13C NMR of compound 2.
Table S1:. Elemental analysis of prepared compounds.
Table S2: Fluorescence intensities of compound 2 (10 μmol L−1) at 520 nm with and without addition of H2S at pH values in the range of 2–12.
Table S3: Fluorescence intensity response of compound 2 to selected analytes at three biological relevant pH values pH = 7.0, pH = 7.2 and pH = 7.4.
Figure S8: (a) Emission spectra of compound 2 excitation at 430 nm, (b) excitation spectra of compound 2 emission at 520 nm, (c) emission spectra of reduced form of compound 2 excitation at 430 nm, and (d) excitation spectra of reduced form of compound 2 emission at 520 nm.
Figure S9: Plot of the fluorescence intensity of compound 2 (10 μmol L−1) in the (a) concentration range of 0–20 μmol L−1 of H2S at 520 nm and (b) concentration range of 0–300 μmol L−1 of H2S at 520 nm.
Figure S10: Determination of H2S concentration in spiked human serum sample using Na2S as internal standard (5–20 μmol L−1) by (a) fluorescent probe detection at 520 nm and (b) UV‐Vis spectrophotometry method using methylene blue in spiked human plasma sample using Na2S as internal standard (5–20 μmol L−1) at 570 nm.
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
